China joins with Philips for biomarker/Dx tests research:
This article was originally published in Clinica
Executive Summary
China's Institute of Health Sciences (IHS) and Royal Philips Electronics signed a memorandum of understanding on August 29 to establish a joint molecular medicine research laboratory. The lab, which will be located at the IHS in Shanghai, will focus on biomarker discovery and the development of next-generation in vitro diagnostic tests, with the aim of developing new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment. The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS).